[Acute fatal bone marrow aplasia after a treatment with a combination of Ambilhar and Mintezol].
D000871:Anthelmintics / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D002648:Child; D004357:Drug Synergism; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D009560:Niridazole / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D012552:Schistosomiasis / Q000188:drug therapy; D013322:Strongyloidiasis / Q000188:drug therapy; D013827:Thiabendazole / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
D000871:Anthelmintics; D007093:Imidazoles; D013844:Thiazoles; D009560:Niridazole; D013827:Thiabendazole; D011241:Prednisone
Sur un cas d'aplasie médullaire aiguë mortelle après traitement par l'association d'Ambilhar et de Mintezol.